LY22-02c

Efficacy and safety of CD19 directed CAR T-cell therapy for transferred follicular lymphoma.

Study #: LY22-02c

Study Status: Published

Presentation(s)

2025, Tandem (Poster)

CD19 directed CAR T therapy for transformed follicular lymphoma: A CIBMTR Analysis.

Citation

Thiruvengadam SK, Ahn KW, Patel J, Lian Q, Hertzberg M, Epperla N, Metheny L, Hong S, Jain T, Aljurf M, Beitinjaneh A, Vaughn J, Gopal A, Iqbal M, Wirk B, Manjappa S, Oliver C, Mohty R, Shadman M, Turtle C, Hamadani M, Herrera AF.

American Journal of Hematology. 2025, Oct 01: 100(10): 100(10):1803-1812. doi: 10.1002/ajh.70027. Epub 2025, Aug 05. PMCID:PMC12582634.

PubMed

PMID: 40762207

Abstract